Detection of occult metastasis in patients with breast cancer

Seminars in Surgical Oncology

Volumn 20, Issue 4, 2001, Pages 312-318

  Hawes, Debra ^a   Neville, A Munro ^b   Cote, Richard J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Bone marrow; Breast cancer; Lymph nodes; Occult metastases; Prognosis

Indexed keywords

BONE MARROW METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; TECHNIQUE;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034768116     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.1049     Document Type: Review

References (69)

1. Rationale for adjuvant chemotherapy
2. Detection of micrometastases in patients with primary breast cancer
3. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow
4. Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: Sensitivity in a model system
5. Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients
6. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
7. Micrometastatic tumor cells in bone marrow in colorectal carcinoma
8. Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance
9. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients
10. Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma
11. Automated screening for micrometastases in bone marrow smears
12. Detection of hematogenous micrometastases in patients with prostate cancer
13. Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer
14. Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in the bone marrow
15. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small cell lung cancer without overt metastases
16. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer
17. Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer
18. Immunohistochemistry in the detection of bone marrow micrometastases in patients with primary lung cancer
19. Detection of occult bone marrow metastases in patients with operable lung carcinoma
20. Clinical relevance of molecular staging for melanoma: Comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma
21. Immunohistochemical detection of occult carcinoma in bone marrow and blood
22. Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction
23. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
24. Mammaglobin gene expression: A superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin19
25. Mammaglobin expression in primary, metastatic, and occult breast cancer
26. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA
27. Mammaglobin, a potential marker of breast cancer nodal metastasis
28. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes
29. Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients
30. Mammaglobin beta as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction
31. RT-PCR detection of breast cancer cells in sentinel lymph nodes
32. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene
33. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: Comparison with immunocytochemistry
34. Detection of circulating tumor cells by reverse-transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy
35. Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer
36. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10-7
37. Detection of breast carcinoma cells in human bone marrow using fluorescent-activated cell sorting and conventional cytology
38. Bone metastases in breast cancer
39. Metastatic bone disease: Clinical and therapeutic aspects
40. The relationship between micrometastases in the bone marrow, histopathologic features in the primary tumor in breast cancer and prognosis
41. Monoclonal antibodies detect occult breast carcinoma metastases in bone marrow of patients with early-stage disease
42. Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases
43. Detection and management of bone marrow micrometastases in breast cancer
44. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients
45. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
46. Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastases
47. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
48. Micrometastases in breast cancer: Long-term follow-up of the first patient cohort
49. Bone marrow micrometastases in primary breast cancer: Prognostic significance after six years' follow-up
50. Immunodiagnosis and immunotherapy of isolated tumor cells disseminated to bone marrow of patients with colorectal cancer
51. Outcome of primary-breastcancer patients with micrometastases: A long-term follow-up study
52. The reliability of histologically negative axillary lymph nodes in breast cancer
53. Axillary lymph node micrometastases and breast cancer
54. Detection and significance of occult metastases in node-negative breast cancer
55. Breast cancer micrometastases in lymph nodes and bone marrow are prognostically important
56. Prognostic factors and primary breast cancer
57. Detection and significance of occult axillary node metastases in patients with invasive breast cancer
58. Significance of occult metastases. A study of breast cancer
59. Occult axillary lymph node metastases in invasive breast carcinoma: Characteristics of the primary tumor and the significance of metastases
60. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast cancer - A study of 97 cases
61. The use of monoclonal antibodies for the histological detection of mammary axillary micrometastases
62. The immunohistochemical detection of lymph node micrometastases from infiltrating lobular carcinoma of the breast
63. Prognostic importance of occult lymph node micrometastases from breast cancers
64. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up
65. Prognostic importance of occult lymph node metastases in patients with breast cancer
66. Micrometastases to axillary lymph nodes from carcinoma of the breast: Detection by immunohistochemistry and prognostic significance
67. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
68. Detection of occult metastases in lung carcinomas: Progress and implications for staging
69. Advances in the pathoogic staging of lung cancer: Detection of regional and systemic occult metastases